3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
69
Carcinoma, Non-Small-Cell Lung
41
Carcinoma, Renal Cell
38
Neoplasm Metastasis
22
Carcinoma, Hepatocellular
15
Neoplasms
14
Colorectal Neoplasms
13
Brain Neoplasms
13
Skin Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Pancreatic Neoplasms
10
Lung Neoplasms
10
Kidney Neoplasms
10
Uveal Melanoma
9
Ovarian Neoplasms
9
Urinary Bladder Neoplasms
8
Sarcoma
8
Prostatic Neoplasms
8
Carcinoma, Transitional Cell
8
Mesothelioma
7
Glioblastoma
7
Clear-cell metastatic renal cell carcinoma
7
Carcinoma, Merkel Cell
7
Recurrence
6
Myelodysplastic Syndromes
6
Colonic Neoplasms
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Multiple Myeloma
5
Mesothelioma, Malignant
5
Interventions
Cyclophosphamide
29
fludarabine phosphate
22
Whole-Body Irradiation
20
Mycophenolic Acid
20
fludarabine
19
asciminib
19
nilotinib
16
Tacrolimus
13
Imatinib Mesylate
13
Melphalan
11
Dasatinib
9
Sirolimus
8
Peripheral Blood Stem Cell Transplantation
8
Thiotepa
7
Granulocyte Colony-Stimulating Factor
7
Busulfan
7
bosutinib
6
Mesna
6
Cyclosporine
6
ponatinib
5
Stem Cell Transplantation
5
Filgrastim
5
venetoclax
4
ruxolitinib
4
blinatumomab
4
Specimen Handling
4
Cyclosporins
4
thymoglobulin
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Ipilimumab
×
1 year
×
Clear all
No trials found.